Tealwood Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.75M | Buy |
14,888
+75
| +0.5% | +$16.1K | 1.44% | 9 |
|
|
2026
Q1 | $3.22M | Sell |
14,813
-118
| -0.8% | -$26.2K | 1.47% | 10 |
|
|
2025
Q4 | $3.41M | Sell |
14,931
-1,061
| -7% | -$242K | 1.53% | 5 |
|
|
2025
Q3 | $3.7M | Sell |
15,992
-175
| -1% | -$35.6K | 1.5% | 5 |
|
|
2025
Q2 | $3M | Sell |
16,167
-330
| -2% | -$61.3K | 1.34% | 8 |
|
|
2025
Q1 | $3.46M | Sell |
16,497
-638
| -4% | -$124K | 1.6% | 3 |
|
|
2024
Q4 | $3.04M | Buy |
17,135
+652
| +4% | +$120K | 1.26% | 15 |
|
|
2024
Q3 | $3.25M | Sell |
16,483
-203
| -1% | -$37.9K | 1.43% | 6 |
|
|
2024
Q2 | $2.86M | Buy |
16,686
+1
| +0% | +$166 | 1.72% | 9 |
|
|
2024
Q1 | $3.04M | Buy |
16,685
+106
| +0.6% | +$18.3K | 1.37% | 6 |
|
|
2023
Q4 | $2.57M | Sell |
16,579
-150
| -0.9% | -$21.9K | 1.23% | 16 |
|
|
2023
Q3 | $2.49M | Hold |
16,729
| – | – | 1.28% | 14 |
|
|
2023
Q2 | $2.25M | Sell |
16,729
-156
| -0.9% | -$22.9K | 1.1% | 22 |
|
|
2023
Q1 | $2.69M | Sell |
16,885
-4,177
| -20% | -$639K | 1.37% | 8 |
|
|
2022
Q4 | $3.4M | Sell |
21,062
-931
| -4% | -$143K | 1.78% | 4 |
|
|
2022
Q3 | $2.95M | Sell |
21,993
-252
| -1% | -$36.2K | 1.6% | 6 |
|
|
2022
Q2 | $3.41M | Sell |
22,245
-704
| -3% | -$108K | 1.69% | 4 |
|
|
2022
Q1 | $3.72M | Sell |
22,949
-232
| -1% | -$33.7K | 1.58% | 4 |
|
|
2021
Q4 | $3.14M | Sell |
23,181
-1,528
| -6% | -$180K | 1.26% | 12 |
|
|
2021
Q3 | $2.67M | Buy |
+24,709
| New | +$2.82M | 1.08% | 24 |
|
|
2021
Q1 | $2.73M | Sell |
25,259
-1,158
| -4% | -$124K | 1.09% | 21 |
|
|
2020
Q4 | $2.83M | Buy |
26,417
+8,276
| +46% | +$795K | 1.33% | 23 |
|
|
2020
Q3 | $1.59M | Buy |
18,141
+10
| +0.1% | +$941 | 1.04% | 35 |
|
|
2020
Q2 | $1.78M | Buy |
+18,131
| New | +$1.6M | 1.18% | 32 |
|
|
2019
Q1 | – | Sell |
-89,211
| Closed | -$8.22M | – | 95 |
|
|
2018
Q4 | $8.22M | Sell |
89,211
-3,957
| -4% | -$348K | 3.9% | 1 |
|
|
2018
Q3 | $8.81M | Sell |
93,168
-3,992
| -4% | -$379K | 3.3% | 1 |
|
|
2018
Q2 | $9M | Sell |
97,160
-4,790
| -5% | -$468K | 3.52% | 1 |
|
|
2018
Q1 | $9.65M | Sell |
101,950
-1,369
| -1% | -$150K | 3.83% | 1 |
|
|
2017
Q4 | $9.99M | Sell |
103,319
-2,706
| -3% | -$255K | 3.7% | 1 |
|
|
2017
Q3 | $9.42M | Sell |
106,025
-851
| -0.8% | -$64.8K | 3.38% | 1 |
|
|
2017
Q2 | $7.75M | Buy |
106,876
+1,572
| +1% | +$106K | 2.9% | 1 |
|
|
2017
Q1 | $6.86M | Buy |
105,304
+1,224
| +1% | +$77K | 2.71% | 3 |
|
|
2016
Q4 | $6.52M | Buy |
104,080
+4,377
| +4% | +$267K | 2.71% | 3 |
|
|
2016
Q3 | $6.29M | Sell |
99,703
-3,086
| -3% | -$200K | 2.78% | 3 |
|
|
2016
Q2 | $6.36M | Buy |
102,789
+53
| +0.1% | +$3.23K | 2.87% | 2 |
|
|
2016
Q1 | $5.87M | Sell |
102,736
-4,590
| -4% | -$256K | 2.63% | 2 |
|
|
2015
Q4 | $5.89M | Sell |
107,326
-4,170
| -4% | -$240K | 2.76% | 4 |
|
|
2015
Q3 | $6.07M | Sell |
111,496
-720
| -0.6% | -$46.9K | 2.65% | 4 |
|
|
2015
Q2 | $7.54M | Buy |
112,216
+780
| +0.7% | +$50.9K | 2.95% | 2 |
|
|
2015
Q1 | $6.52M | Sell |
111,436
-3,885
| -3% | -$235K | 2.67% | 2 |
|
|
2014
Q4 | $7.55M | Buy |
115,321
+1,466
| +1% | +$92.4K | 2.97% | 2 |
|
|
2014
Q3 | $6.58M | Buy |
+113,855
| New | +$6.32M | 2.57% | 4 |
|
Other funds holding ABBV
ECSS
ATO
Tealwood Asset Management's ABBV Position: Q2 2026 in Review
Tealwood Asset Management increased its AbbVie (ABBV) stake by 0.51% in Q2 2026, buying an estimated $16.1K and bringing the position to 14,888 shares worth $3.75M. The position accounts for 1.44% of the portfolio, ranked #9.
Tealwood Asset Management first reported a position in ABBV in Q3 2014 and has held it in 42 quarters since. The position peaked at $9.99M in Q4 2017. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Tealwood Asset Management held 14,888 shares of AbbVie worth $3.75M as of Q2 2026.
- Tealwood Asset Management bought 75 AbbVie shares in Q2 2026, an estimated $16.1K.
- AbbVie made up 1.44% of Tealwood Asset Management's portfolio in Q2 2026, its #9 holding.
- Tealwood Asset Management first reported a position in AbbVie in Q3 2014 and has held it in 42 quarters since.
- Tealwood Asset Management's AbbVie position peaked at $9.99M in Q4 2017.
- 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.